Personal information

No personal information available

Activities

Collapse all

Employment (1)

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital: Chengdu, Sichuan, CN

Employment
Source: Self-asserted source
Limei Yin

Education and qualifications (1)

Sichuan University: Chengdu, CN

PhD (Department of Oncology)
Education
Source: Self-asserted source
Limei Yin

Works (10)

Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer.

Med (New York, N.Y.)
2024-07-02 | Journal article
DOI: 10.1016/j.medj.2024.06.002
PMID: 38964333
Contributors: Wang H; Yao Z; Kang K; Zhou L; Xiu W; Sun J; Xie C; Yu M; Li Y; Zhang Y et al.
Source: Self-asserted source
Limei Yin

Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients.

Clinical cancer research : an official journal of the American Association for Cancer Research
2023-10-01 | Journal article | Author
DOI: 10.1158/1078-0432.ccr-23-0315
PMID: 37581611
Contributors: Xiaojuan Zhou; Laiyan Zhou; Zhuoran Yao; Meijuan Huang; Youling Gong; Bingwen Zou; Jiang Zhu; Yongmei Liu; Feng Peng; Yan Zhang et al.
Source: Self-asserted source
Limei Yin

Time to abandon CAR-T monotherapy for solid tumors.

Biochimica et biophysica acta. Reviews on cancer
2023-06-05 | Review
DOI: 10.1016/j.bbcan.2023.188930
PMID: 37286147
Contributors: Yin L; Zhengwei Wan; Sun P; Shuai P; Liu Y
Source: Self-asserted source
Limei Yin

The Dynamic Alternation of Local and Systemic Tumor Immune Microenvironment During Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial.

International journal of radiation oncology, biology, physics
2021-03-10 | Journal article
DOI: 10.1016/j.ijrobp.2021.03.003
PMID: 33713744
Contributors: Li R; Liu Y; Yin R; Yin L; Li K; Sun C; Zhou Z; Li P; Tong R; Jianxin Xue et al.
Source: Self-asserted source
Limei Yin

Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer.

International journal of radiation oncology, biology, physics
2020-05-15 | Journal article
DOI: 10.1016/j.ijrobp.2020.05.002
PMID: 32417411
Contributors: Yin L; Jianxin Xue; Li R; Zhou L; Lei Deng; Chen L; Zhang Y; Li Y; Zhang X; Xiu W et al.
Source: Self-asserted source
Limei Yin

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.

Nature medicine
2020-04-27 | Journal article
DOI: 10.1038/s41591-020-0840-5
PMID: 32341578
Contributors: You Lu; You-Lu; Jianxin Xue; Deng T; Zhou X; Yu K; Deng L; Huang M; Yi X; Liang M et al.
Source: Self-asserted source
Limei Yin

Synergy between peroxisome proliferator-activated receptor γ agonist and radiotherapy in cancer.

Cancer science
2018-06-16 | Journal article | Author
DOI: 10.1111/cas.13650
PMID: 29791764
PMC: PMC6029840
Contributors: Guodong Huang; Limei Yin; Lan J; Tong R; Li M; Na F; Mo X; Chen C; Xue J; You Lu et al.
Source: Self-asserted source
Limei Yin

Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy.

International journal of radiation oncology, biology, physics
2018-03-12 | Journal article
DOI: 10.1016/j.ijrobp.2018.01.071
PMID: 29619980
Contributors: Lan J; Li R; Yin LM; Lei Deng; Jun Gui; Chen BQ; Zhou L; Meng MB; Huang QR; Mo XM et al.
Source: Self-asserted source
Limei Yin

PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2018-02-20 | Journal article
DOI: 10.1016/j.biopha.2018.01.095
PMID: 29653486
Contributors: Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Lei Deng et al.
Source: Self-asserted source
Limei Yin

Assessment of programmed cell death ligand-1 expression with multiple immunohistochemistry antibody clones in non-small cell lung cancer.

Journal of thoracic disease
2018-02-01 | Journal article
DOI: 10.21037/jtd.2018.01.124
PMID: 29607153
PMC: PMC5864642
Contributors: Pang C; Yin L; Zhou X; Lei C; Tong R; Huang M; Gong Y; Ding Z; Xue J; Zhu J et al.
Source: Self-asserted source
Limei Yin
How many people are using ORCID?